Epstein-Barr virus infection associated with pepsinogens and Helicobacter pylori infection in patients with gastric cancer
Epstein-Barr virus infection associated with pepsinogens and Helicobacter pylori infection in patients with gastric cancer
复制标题
胃癌患者中 Epstein-Barr 病毒感染与胃蛋白酶原和幽门螺杆菌感染相关。
DOI:
10.1016/j.virusres.2018.07.017
复制
发表时间:
2018-09-02
期刊:
影响因子:
5
通讯作者:
He, Caiyun
中科院分区:
文献类型:
--
作者:
Su, Xuan;Ye, Zulu;He, Caiyun
Background: There is no study reporting the influence of the Epstein-Barr virus (EBV) infection on the biomarkers of gastric function like pepsinogen (PG) I and II in patients with gastric cancer, and the relationship between the infection of EBV and Helicobacter pylori (HP) is unclear. This study focused on these issues.Methods: In this study, we detected the serum levels of PGI, PGII, anti-HP (immunoglobulin G) IgG antibodies and EBV DNA load in a total of 189 gastric cancer patients confirmed to be EBV positive or negative in tissue using in situ hybridization of EBV-encoded small RNAs (EBERs).Results: Compared to 123 EBV negative gastric cancer patients, the 66 patients infected with EBV exhibited significant higher levels of PGI and PGI/II ratio and meanwhile, had remarkably lower levels of anti-HP IgG. The prevalence of HP infection in EBV positive patients was 13.6%, and 52.8% in EBV negative patients. In subsequent analysis concerning the EBV DNA load, the patients were divided into two groups by a cutoff value of 1000 copies/ml. The EBV DNA load showed highly consistent association with PGI, PGI/II ratio and HP.Conclusions: EBV infection in situ increased the serum levels of PGI and ratio of PGI/PGII in gastric cancer patients. Moreover, the EBV infection exclusively exists with HP infection in the patients with gastric cancer.